You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3101 to 3125 of about 5880
Next 25
11/22/2009
Montgomery couple remembers the daughter they lost to DIPG
20-25 Per Cent Of Brain Cancer Patients Show Verbal And Physical Aggression
11/21/2009
European advisory committee declines to recommend Avastin approval for deadly brain cancer
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
11/13/2009
Cooking up a CURE for brain tumors
Neurosurgery Resident`s Book Helps Ease Youths` Fears About Brain Surgery
11/12/2009
Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.
11/10/2009
Tampa Bay Lightning and Miles For Hope Present Ticket To A Cure To Fund Brain Cancer Research
New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine`s Bavituximab With Radiation in a Lethal Brain Cancer Model
11/09/2009
The Florida Brain Tumor Association & Moffitt Cancer Center Brain Tumor Conference Jan 22-23
11/05/2009
Therapy-related myelodysplastic syndrome/acute myeloid leukemia after treatment with temozolomide in a patient with glioblastoma multiforme.
11/03/2009
MagForce Successfully Completes Final Clinical Trials for Nano-Cancer Therapy
Gamma knife treatment for glioblastomas shows promising results - Survival rate increased by almost 4 months
Brains behind operation
11/01/2009
Added 2009 update to Ben Williams`s article on treatment options for malignant brain tumors
Treatment Options For Malignant Gliomas - by Dr Ben Williams - 2009 Update.
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults.
Cancer drug from Cuba undergoes rare U.S. trial (for brainstem glioma as well as GBMs)
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma.
Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
10/29/2009
Electrifying Brain Tumors
Myriad Pharmaceuticals` Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R)
ImmunoCellular`s Promising Brain Cancer Vaccine
4th Annual Dallas-Ft. Worth Brain Tumor Walk Raising Essential Funds for Brain Tumor Research